Riskpilot← Back to searchSign inGet full accessEnceladusMed AB
ABActiveOrg 5590770342Primusgatan 96 Lgh 1602General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 0
EBITDA margin
—
-106% vs 2024
Equity ratio
65.2%
Financial strength
Net profit 2025
SEK 123K
-70% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -27K | -106% |
| Net profit | SEK 123K | -70% |
| Total assets | SEK 3M | -12% |
| Equity | SEK 2M | -4% |
| Employees | 0 | — |
Legal name
EnceladusMed AB
Org number
5590770342
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 september 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utbilda och förmedla personal, företrädesvis inom vårdsektorn, bedriva läkarkonsultation och utbildning, förvalta fast och lös egendom, ävensom idka därmed förenlig verksamhet.
Address
Primusgatan 96 Lgh 1602
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 032 | 987 | 872 | 775 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 850 | 669 | 568 | 442 | −27 |
| Depreciation & amort. | −96 | −96 | −96 | −6 | −6 |
| EBIT | 754 | 573 | 472 | 436 | −33 |
| Net financials | — | 3 | 50 | 151 | 14 |
| Profit before tax | 563 | 431 | 553 | 542 | 163 |
| Tax | −118 | −90 | −126 | −124 | −40 |
| Net profit | 445 | 341 | 427 | 418 | 123 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 712 | 2 965 | 3 201 | 3 398 | 3 007 |
| Equity | 1 449 | 1 603 | 1 835 | 2 047 | 1 961 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 285 | 239 | 274 | 213 | 90 |
| Total debt | 285 | 239 | 274 | 213 | 90 |
EBITDA margin
-2693500.0%
This company
15.8%
Market median
-17047568% vs market
20212025
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20212025
Return on equity
6.3%
This company
18.4%
Market median
-66% vs market
20212025
Net profit margin
12349700.0%
This company
8.1%
Market median
+152465332% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EnceladusMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Orsolya Maria Hoffmann | Board of Directors | 0 companies |
| Erik Gabor Hoffmann | Deputy Board Member | 0 companies |